Brief: Grand Pharmaceutical Posts FY Revenue Of HKD 11,644.89 Mln
12/03/2025 14:56
March 12 (Reuters) - Grand Pharmaceutical Group Ltd 0512.HK: FY REVENUE HKD 11,644.89 MILLION FY NET INCOME ATTRIBUTABLE HKD 2,468.38 MILLION RECOMMENDS PAYMENT OF FINAL DIVIDEND OF HK$0.26 PER SHARE FOR 2024 Further company coverage: 0512.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Grand Pharmaceutical
See all newsBrief: Grand Pharmaceutical Group Declares No Interim Dividend Has Been Paid
Grand Pharmaceutical H1 revenue rises on nuclear medicine demand
Grand Pharma rises most in over a year as drug gets US FDA fast track designation
GPN01530-2 Granted Fast Track Designation By FDA
Brief: Grand Pharmaceutical Group Enters Huadong Medicine Supply Agreement